Lakshman, A http://orcid.org/0000-0001-8915-2382
Alhaj Moustafa, M
Rajkumar, S V
Dispenzieri, A
Gertz, M A
Buadi, F K
Lacy, M Q
Dingli, D
Fonder, A L
Hayman, S R
Hobbs, M A
Gonsalves, W I
Hwa, Y L
Kapoor, P
Leung, N http://orcid.org/0000-0002-5651-1411
Go, R S
Lin, Y
Kourelis, T V
Lust, J A
Russell, S J
Zeldenrust, S R
Kyle, R A
Kumar, S K
Article History
Received: 12 May 2017
Revised: 7 June 2017
Accepted: 19 June 2017
First Online: 27 June 2017
Competing interests
: AD received research funding from Celgene, Millennium, Pfizer and Janssen and travel grant from Pfizer. MAG received consulting fees from Millenium and honoraria from Celgene, Millenium, Onyx, Novartis, Smith Kline, Prothena, Ionis and Amgen. MQL received research funding from Celgene. PK received research funding from Takeda, Celgene and Amgen. SKK received consulting fees from Celgene, Millennium, Onyx, Janssen and BMS and research funding from Celgene, Millennium, Novartis, Onyx AbbVie, Janssen and BMS. The remaining authors declare no competing financial interest.